Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20240725003
TCTR20240725003
Not yet recruiting
Phase 2

Adjuvant chemotherapy plus radiation versus chemotherapy alone in stage III-IVA endometrial cancer: a phase II randomized controlled trial

Mahidol University0 sites75 target enrollmentJuly 25, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEvaluate pelvic recurrent rate and survival outcome in stage III-IVA endometrial cancer who receive adjuvant chemotherapy plus radiation versus chemotherapy aloneendometrial cancerradiationadjuvant treatment

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Evaluate pelvic recurrent rate and survival outcome in stage III-IVA endometrial cancer who receive adjuvant chemotherapy plus radiation versus chemotherapy alone
Sponsor
Mahidol University
Enrollment
75
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2024
End Date
August 1, 2027
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •1\. Participants must be 18 years of age or older.
  • •2\. Participants must have been diagnosed with stage III\-IVA endometrial cancer through surgical staging at Siriraj Hospital.
  • •3\. Participants must not have any suspicious pathological lymph nodes on radiographic imaging (CT scan, MRI, or PET scan) following chemotherapy.

Exclusion Criteria

  • •1\. Participants who have progression of disease of during or after receiving chemotherapy.
  • •2\. Participants who develop secondary cancer while participating in the research study.
  • •3\. Participants who have previously received radiation therapy to the pelvic area.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
eoadjuvant chemoradiotherapy vs. chemotherapy alone in locally advanced esophageal squamous cell carcinoma: randomized phase II studyNeoplasms
KCT0002181Seoul National University Hospital114
Recruiting
Phase 3
Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer ; a phase 3 trialPatients with high-recurrent risk, stage IB-IIB cervical cancer after radical hysterectomyCervical cancer
JPRN-jRCTs041190042Furusawa Akiko250
Not yet recruiting
Not Applicable
Adjuvant Chemotherapy Versus Radiotherapy For Postoperative Cervical Cancer (AFTER): A Phase 3 Trial
KCT0006893Konkuk University Medical Center50
Recruiting
Not Applicable
Therapy used for Carcinoma Gallbladder after Surgery
CTRI/2018/01/011296Dr Shivendra Singh
Recruiting
Phase 3
eoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancercarcinoma of the oesophagusoesophageal cancer1001799010017991
NL-OMON50242Erasmus MC, Universitair Medisch Centrum Rotterdam738